Ahmed M. Gouda

2.1k citations
52 papers · 1.7k · 1 hit paper · h-index 26

Impact in

  • Toxicology top 2%
    • Bioactive Compounds and Antitumor Agents
  • Organic Chemistry top 2%
    • Synthesis and biological activity
    • Click Chemistry and Applications
    • Synthesis and Biological Evaluation
    • Quinazolinone synthesis and applications
    • Synthesis and Characterization of Heterocyclic Compounds

Papers in

  • Organic Chemistry 36
    • Synthesis and biological activity 25
    • Click Chemistry and Applications 6
    • Synthesis and Reactivity of Heterocycles 5
    • Chemical synthesis and pharmacological studies 4
  • Molecular Biology 26
    • Cancer therapeutics and mechanisms 17
Co-authors
Ashraf N. Abdalla (17 shared papers)Ahmed H. Abdelazeem (13 shared papers)Bahaa G. M. Youssif (15 shared papers)Mohammed A. S. Abourehab (10 shared papers)Ahmed M. Shawky (9 shared papers)Faisal A. Almalki (9 shared papers)Alaa M. Alqahtani (5 shared papers)Mohamed Abdel‐Aziz (6 shared papers)
Journals
Bioorganic Chemistry (15 papers)European Journal of Medicinal Chemistry (8 papers)Molecules (6 papers)Journal of Chromatographic Science (2 papers)Journal of Enzyme Inhibition and Medicinal Chemistry (2 papers)
Partner nations
EgyptSaudi ArabiaSudan

In The Last Decade

Ahmed M. Gouda

50 papers receiving 1.6k citations

Ahmed M. Gouda's Hit Papers

A Comprehensive Overview of Globally Approved JAK Inhibitors 2022 · 214 citations
2140+1+2Years since publication50100150200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

  • it has ≥500 total citations;
  • it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
  • it reaches the top citation threshold in at least one of its specific research topics.
  1. 2022 Pharmaceutics

Peers

Ahmed M. Gouda
Comparison fields: 5 of 98
  • Toxicology 117
  • Organic Chemistry 979
  • Oncology 304
  • Pharmacology 143
  • Molecular Biology 606
Replace Ahmed H. Abdelazeem with:
Ahmed H. Abdelazeem Egypt
Xuewei Wu China
Zhuang Yang China
Mohamed Ashraf Ali Malaysia
Dalal A. Abou El Ella Egypt
Giovanni Marzaro Italy
Linxiang Zhao China
Bahaa G. M. Youssif Egypt
Paul Tunnah France
Liying Ma China
Ahmed M. Gouda relative to Ahmed H. Abdelazeem Egypt Ahmed H. Abdelazeem's profile →
Citations per field
00.5×1.6×
Ahmed H. Abdelazeem · 1×
Citations per year

Countries citing papers authored by Ahmed M. Gouda

Since Specialization
Citations

This map shows the geographic impact of Ahmed M. Gouda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmed M. Gouda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmed M. Gouda more than expected).

Fields of papers citing papers by Ahmed M. Gouda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ahmed M. Gouda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmed M. Gouda. The network helps show where Ahmed M. Gouda may publish in the future.

Co-authors

The 25 scholars most cited alongside Ahmed M. Gouda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ahmed M. Gouda Line = papers co-authored together Ahmed M. Gouda links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A Comprehensive Overview of Globally Approved JAK Inhibitors
Pharmaceutics ·Ahmed M. Shawky, Faisal A. Almalki, Ashraf N. Abdalla, Ahmed H. Abdelazeem, Ahmed M. Gouda
Hit paper breakdown →		2022214
2
Globally Approved EGFR Inhibitors: Insights into Their Syntheses, Target Kinases, Biological Activities, Receptor Interactions, and Metabolism
Molecules ·Mohammed A. S. Abourehab, Alaa M. Alqahtani, Bahaa G. M. Youssif, Ahmed M. Gouda
2021138
3
Design and synthesis of novel quinoline/chalcone/1,2,4-triazole hybrids as potent antiproliferative agent targeting EGFR and BRAFV600E kinases
Bioorganic Chemistry ·Aliaa M. Mohassab, Heba A. Hassan, Dalia Abdelhamid, Ahmed M. Gouda, Bahaa G. M. Youssif, Hiroshi Tateishi, Mikako Fujita, Masami Otsuka, Mohamed Abdel‐Aziz
202099
4
Design and synthesis of novel 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivatives as antiproliferative EGFR and BRAFV600E dual inhibitors
Bioorganic Chemistry ·Lamya H. Al-Wahaibi, Ahmed M. Gouda, Ola F. Abou‐Ghadir, Ola I. A. Salem, Asmaa T. Ali, Hatem S. Farghaly, Mostafa Abdelrahman, Laurent Trembleau, Hajjaj H.M. Abdu-Allah, Bahaa G. M. Youssif
202067
5
Design, synthesis, and biological evaluation of novel EGFR inhibitors containing 5-chloro-3-hydroxymethyl-indole-2-carboxamide scaffold with apoptotic antiproliferative activity
Bioorganic Chemistry ·Fatma A. Mohamed, Hesham A. M. Gomaa, Omnia M. Hendawy, Asmaa T. Ali, Hatem S. Farghaly, Ahmed M. Gouda, Ahmed H. Abdelazeem, Mostafa Abdelrahman, Laurent Trembleau, Bahaa G. M. Youssif
202163
6
Optimization of pyrrolizine-based Schiff bases with 4-thiazolidinone motif: Design, synthesis and investigation of cytotoxicity and anti-inflammatory potency
European Journal of Medicinal Chemistry ·Ahmed M. Shawky, Mohammed A. S. Abourehab, Ashraf N. Abdalla, Ahmed M. Gouda
201960
7
Optimization and SAR investigation of novel 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivatives as EGFR and BRAFV600E dual inhibitors with potent antiproliferative and antioxidant activities
Bioorganic Chemistry ·Hesham A. M. Gomaa, Mohamed E. Shaker, Sami I. Alzarea, Omnia M. Hendawy, Fatma A. Mohamed, Ahmed M. Gouda, Asmaa T. Ali, Martha M. Morcoss, Mostafa Abdelrahman, Laurent Trembleau, Bahaa G. M. Youssif
202253
8
Design and synthesis of new 1,6-dihydropyrimidin-2-thio derivatives targeting VEGFR-2: Molecular docking and antiproliferative evaluation
Bioorganic Chemistry ·Adel A. Marzouk, Salah A. Abdel‐Aziz, Kamal Abdelrahman, Amira S. Wanas, Ahmed M. Gouda, Bahaa G. M. Youssif, Mohamed Abdel‐Aziz
202053
9
Novel 1,2,4-triazole derivatives as apoptotic inducers targeting p53: Synthesis and antiproliferative activity
Bioorganic Chemistry ·Hesham A. M. Gomaa, Hany A.M. El-Sherief, Shaimaa Hussein, Ahmed M. Gouda, Ola I. A. Salem, Khalid Saad Alharbi, Alaa M. Hayallah, Bahaa G. M. Youssif
202046
10
Antitumor activity of pyrrolizines and their Cu(II) complexes: Design, synthesis and cytotoxic screening with potential apoptosis-inducing activity
European Journal of Medicinal Chemistry ·Ahmed M. Gouda, Hoda A. El‐Ghamry, Tahani M. Bawazeer, Thoraya A. Farghaly, Ashraf N. Abdalla, Akhmed Aslam
201845
11
Design and synthesis of new triarylimidazole derivatives as dual inhibitors of BRAFV600E/p38α with potential antiproliferative activity
Journal of Molecular Structure ·Bahaa G. M. Youssif, Ahmed M. Gouda, Amr H. Moustafa, Antar A. Abdelhamid, Hesham A. M. Gomaa, Islam Kamal, Adel A. Marzouk
202144
12
Design, synthesis and antitrypanosomal activity of heteroaryl-based 1,2,4-triazole and 1,3,4-oxadiazole derivatives
Bioorganic Chemistry ·Montaser Sh. A. Shaykoon, Adel A. Marzouk, Osama M. Soltan, Amira S. Wanas, Mohamed M. Radwan, Ahmed M. Gouda, Bahaa G. M. Youssif, Mohamed Abdel‐Aziz
202042
13
Novel substituted and fused pyrrolizine derivatives: Synthesis, anti-inflammatory and ulcerogenecity studies
European Journal of Medicinal Chemistry ·Safinaz E. Abbas, Fadi M. Awadallah, Nashwa A. Ibrahim, Ahmed M. Gouda
200941
14
Design, synthesis and biological evaluation of novel 5-((substituted quinolin-3-yl/1-naphthyl) methylene)-3-substituted imidazolidin-2,4-dione as HIV-1 fusion inhibitors
Bioorganic Chemistry ·Tarek S. Ibrahim, Riham M. Bokhtia, Amany M. M. Al‐Mahmoudy, Ehab S. Taher, Mohammed A. AlAwadh, Mohamed Elagawany, Eatedal H. Abdel‐Aal, Siva S. Panda, Ahmed M. Gouda, Hany Z. Asfour, Nabil A. Alhakamy, Bahaa G. M. Youssif
202038
15
Arylpropionic acid-derived NSAIDs: New insights on derivatization, anticancer activity and potential mechanism of action
Bioorganic Chemistry ·Ahmed M. Gouda, Eman A. M. Beshr, Faisal A. Almalki, Hadeel H. Halawah, Batool Fawzi Taj, Athir Faiz Alnafaei, Rahaf Sulaiman Alharazi, Weam Mahmood Kazi, Malak Mohammad Almatrafi
201937
16
Design, synthesis and biological evaluation of novel diphenylthiazole-based cyclooxygenase inhibitors as potential anticancer agents
Bioorganic Chemistry ·Ahmed H. Abdelazeem, Ahmed M. Gouda, Hany A. Omar, Mai F. Tolba
201435
17
Ethyl benzoate bearing pyrrolizine/indolizine moieties: Design, synthesis and biological evaluation of anti-inflammatory and cytotoxic activities
Bioorganic Chemistry ·Khalid M. Attalah, Ashraf N. Abdalla, Akhmed Aslam, Muhammad Ahmed, Mohammed A. S. Abourehab, Naser A. ElSawy, Ahmed M. Gouda
201935
18
Design, Synthesis, and Biological Evaluation of Some Novel Pyrrolizine Derivatives as COX Inhibitors with Anti-Inflammatory/Analgesic Activities and Low Ulcerogenic Liability
Molecules ·Ahmed M. Gouda, Hamed I. Ali, Waleed Hassan Almalki, Mohamed S. Abdel Azim, Mohammed A. S. Abourehab, Ahmed H. Abdelazeem
201634
19
Pharmacophore-based virtual screening, synthesis, biological evaluation, and molecular docking study of novel pyrrolizines bearing urea/thiourea moieties with potential cytotoxicity and CDK inhibitory activities
Journal of Enzyme Inhibition and Medicinal Chemistry ·Ahmed M. Shawky, Nashwa A. Ibrahim, Mohammed A. S. Abourehab, Ashraf N. Abdalla, Ahmed M. Gouda
202033
20
Design, synthesis and pharmacological evaluation of novel pyrrolizine derivatives as potential anticancer agents
Bioorganic Chemistry ·Ahmed M. Gouda, Ahmed H. Abdelazeem, El‐Shaimaa A. Arafa, Khaled R.A. Abdellatif
201431

About Ahmed M. Gouda

Ahmed M. Gouda is a scholar working on Organic Chemistry, Molecular Biology, Pharmacology, Computational Theory and Mathematics and Toxicology, having authored 52 papers that have together received 1.7k indexed citations. Recurring topics across this work include Synthesis and biological activity (25 papers), Cancer therapeutics and mechanisms (17 papers), Inflammatory mediators and NSAID effects (9 papers), Computational Drug Discovery Methods (9 papers), Bioactive Compounds and Antitumor Agents (7 papers), Click Chemistry and Applications (6 papers), Synthesis and Reactivity of Heterocycles (5 papers) and Chemical synthesis and pharmacological studies (4 papers). The work is most often cited by research in Toxicology (117 citations), Organic Chemistry (979 citations), Oncology (304 citations), Pharmacology (143 citations) and Molecular Biology (606 citations). Ahmed M. Gouda has collaborated with scholars based in Egypt, Saudi Arabia and Sudan. Frequent co-authors include Ashraf N. Abdalla, Ahmed H. Abdelazeem, Bahaa G. M. Youssif, Mohammed A. S. Abourehab, Ahmed M. Shawky, Faisal A. Almalki, Alaa M. Alqahtani, Mohamed Abdel‐Aziz, Hesham A. M. Gomaa and Mostafa Abdelrahman. Their work appears in journals such as Bioorganic Chemistry, European Journal of Medicinal Chemistry, Molecules, Journal of Chromatographic Science and Journal of Enzyme Inhibition and Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ahmed H. AbdelazeemBreakdown of academic impact, for papers by Xuewei WuBreakdown of academic impact, for papers by Zhuang YangBreakdown of academic impact, for papers by Mohamed Ashraf AliBreakdown of academic impact, for papers by Dalal A. Abou El EllaBreakdown of academic impact, for papers by Giovanni MarzaroBreakdown of academic impact, for papers by Linxiang ZhaoBreakdown of academic impact, for papers by Bahaa G. M. YoussifBreakdown of academic impact, for papers by Paul TunnahBreakdown of academic impact, for papers by Liying Ma